Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Allergy Asthma Immunol Res ; 7(4): 384-92, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25749774

ABSTRACT

PURPOSE: Divergent results on the IgE reactivity of dog-allergic subjects to Can f 4 have been reported. The aim of this study was to evaluate the significance of Can f 4 in dog allergy and to develop an immunochemical method for measuring Can f 4 content in environmental samples. METHODS: We purified the natural dog allergen Can f 4 from a dog dander extract by monoclonal antibody-based affinity chromatography and generated its variant in a recombinant form. Sixty-three dog-allergic patients and 12 nonallergic control subjects were recruited in the study. The IgE-binding capacity of natural Can f 4 and its recombinant variant was assessed by ELISA, immunoblotting, and skin prick tests (SPT). RESULTS: Eighty-one percent of the dog-allergic patients showed a positive result to the immunoaffinity-purified natural Can f 4 in IgE ELISA, but only 46% in IgE immunoblotting. Respective results with the recombinant Can f 4 variant were 54% and 49%. SPT results reflected those obtained in ELISA and immunoblotting. The overall IgE reactivity of the immunoaffinity-purified natural Can f 4 was found to depend strongly on the integrity of the allergen's conformation. A sandwich ELISA based on monoclonal antibodies was found to be functional for measuring Can f 4 in environmental samples. CONCLUSIONS: Can f 4 is a major allergen of dog together with Can f 1 and Can f 5. In combination with other dog allergens, it improves the reliability of allergy tests in dog allergy.

2.
Immunobiology ; 217(1): 8-12, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21962572

ABSTRACT

Allergic sensitization results from a complex interaction between genetic and environmental factors. Earlier studies have shown that highly polymorphic HLA genes are associated with a variety of allergies. Several important respiratory allergens belong to the family of lipocalin proteins. These include occupational sensitizers, such as cow Bos d 2 or rat Rat n 1, and prevalent indoor sensitizers, such as dog Can f 1 or cockroach Bla g 4. HLA associations with sensitization to lipocalin allergens are incompletely known. In the present study we have investigated an association between HLA alleles and sensitization to the major cow allergen Bos d 2. The HLA-DR/DQ genotypes of 40 Bos d 2-sensitized subjects having occupational asthma were determined by polymerase chain reaction (PCR) and the results were compared with the genotypes of 151 unrelated Finnish subjects. The frequencies of HLA class II alleles DRB1*0101, DRB1*0404, DQB1*0302, and DQB1*0501 were significantly higher among Bos d 2-sensitized than among control subjects. In addition, the allergic subjects expressed significantly lower frequencies of HLA-DRB1*0301 and DQB1*0201 alleles than did the control subjects. These data suggest that the HLA class II alleles DRB1*0101, DRB1*0404, DQB1*0302, and DQB1*0501, and the haplotypes that include them, are associated with sensitization to the major cow allergen Bos d 2, whereas HLA-DRB1*0301 and DQB1*0201 are dissociated with it. Amino acid analysis provides a biologically plausible explanation for the HLA associations.


Subject(s)
Antigens, Plant/immunology , Asthma, Occupational/immunology , Gene Frequency/immunology , HLA-DQ beta-Chains/immunology , HLA-DR beta-Chains/immunology , Hypersensitivity/immunology , Adult , Alleles , Allergens , Animals , Antigens, Plant/genetics , Antigens, Plant/metabolism , Asthma, Occupational/genetics , Asthma, Occupational/metabolism , Binding Sites , Case-Control Studies , Cattle , Female , Genotype , HLA-DQ beta-Chains/genetics , HLA-DQ beta-Chains/metabolism , HLA-DR beta-Chains/genetics , HLA-DR beta-Chains/metabolism , Haplotypes , Humans , Hypersensitivity/genetics , Hypersensitivity/metabolism , Lipocalins/genetics , Lipocalins/immunology , Lipocalins/metabolism , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Genetic , Protein Binding
3.
Eur J Immunol ; 40(9): 2460-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20690179

ABSTRACT

Although allergen-specific CD4(+) T cells are detectable in the peripheral blood of both individuals with or without allergy, their frequencies and phenotypes within the memory as well as naïve repertoires are incompletely known. Here, we analyzed the DRB1*0401-restricted responses of peripheral blood-derived memory (CD4(+)CD45RO(+)) and naïve (CD4(+)CD45RA(+)) T cells from subjects with or without allergy against the immunodominant epitope of the major cow dander allergen Bos d 2 by HLA class II tetramers in vitro. The frequency of Bos d 2(127-142)-specific memory T cells in the peripheral blood-derived cultures appeared to be higher in subjects with allergy than those without, whereas naïve Bos d 2(127-142)-specific T cells were detectable in the cultures of both groups at nearly the same frequency. Surprisingly, the TCR avidity of Bos d 2(127-142)-specific T cells of naïve origin, as assessed by the intensity of HLA class II tetramer staining, was found to be higher in individuals with allergy. Upon restimulation, long-term Bos d 2(127-142)-specific T-cell lines generated from both memory and naïve T-cell pools from individuals with allergy proliferated more strongly, produced more IL-4 and IL-10, and expressed higher levels of CD25 but lower levels of CXCR3 than the T-cell lines from individuals without allergy, demonstrating differences also at the functional level. Collectively, our current results suggest that not only the memory but also the naïve allergen-specific T-cell repertoires differ between individuals with or without allergy.


Subject(s)
Allergens/immunology , Hypersensitivity/immunology , Peptide Fragments/immunology , T-Lymphocyte Subsets/metabolism , Th2 Cells/metabolism , Animals , Antigens, Plant , CD4 Antigens/biosynthesis , Cattle/immunology , Cells, Cultured , Cytokines/metabolism , HLA-DR Antigens/immunology , HLA-DR Antigens/metabolism , HLA-DRB1 Chains , Humans , Hypersensitivity/diagnosis , Hypersensitivity/pathology , Immunologic Memory , Immunophenotyping , Leukocyte Common Antigens/biosynthesis , Protein Binding , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell/metabolism , Receptors, CXCR3/biosynthesis , Receptors, CXCR3/genetics , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/pathology , Th2 Cells/immunology , Th2 Cells/pathology
4.
Mol Immunol ; 46(16): 3320-7, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19700193

ABSTRACT

We have previously proposed that mammalian lipocalin allergens are recognized suboptimally by the human immune system due to their homology with endogenous lipocalins. Here, we have characterized in detail the human T cell recognition of one of the previously identified T cell epitopes of the major dog allergen Can f 1, contained in peptide p105-120. A panel of peptide analogues (altered peptide ligands, APLs) of p105-120 was tested on two specific T cell clones restricted by different human leukocyte antigen (HLA) alleles. Interestingly, we identified for both of the clones several heteroclitic APLs that were capable of stimulating them at 10-30-fold lower concentrations than the natural peptide. Moreover, one of the heteroclitic APLs identified with the T cell clones, L115F, was observed to induce a stronger polyclonal T cell response than the natural allergen peptide from the peripheral blood mononuclear cells (PBMCs) of six Can f 1-allergic subjects studied. The heteroclitic APLs bound with the same affinity as p105-120 to common HLA-DR- and HLA-DP-alleles, suggesting that their improved stimulatory capacity is attributable to a more efficient T cell receptor (TCR) recognition rather than increased HLA binding. Collectively, our data suggest that p105-120 is recognized suboptimally by human T cells. This may contribute to the allergenicity of Can f 1.


Subject(s)
Allergens/immunology , Epitopes, T-Lymphocyte/immunology , Hypersensitivity/immunology , Peptides/immunology , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology , Alleles , Allergens/genetics , Animals , Antigens, Plant , Cells, Cultured , Dogs , Dose-Response Relationship, Drug , Epitopes, T-Lymphocyte/genetics , HLA-DP Antigens/genetics , HLA-DP Antigens/immunology , HLA-DR Antigens/genetics , HLA-DR Antigens/immunology , Humans , Hypersensitivity/genetics , Lipocalins/genetics , Lipocalins/immunology , Peptides/genetics , Peptides/pharmacology , Receptors, Antigen, T-Cell/genetics
5.
Immunology ; 123(3): 358-66, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17944901

ABSTRACT

Lipocalin allergens, which contain most of the important animal-derived respiratory sensitizers, induce T helper type 2 (Th2) deviation, but the reasons for this are not clear. To explore the prospects for peptide-based allergen immunotherapy and to elucidate the characteristics of the immunodominant epitope of Bos d 2, BALB/c mice were immunized with a peptide containing the epitope, peptides containing its analogues, peptides from the corresponding regions of other lipocalin proteins, and peptides with a homologous sequence. We observed that murine spleen cells recognized the immunodominant epitope of Bos d 2, p127-142, in almost the same way as human Bos d 2-specific T cells did. Enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) analyses showed that p127-142 and a corresponding peptide from horse Equ c 1 induced a Th2-deviated cellular response, whereas a homologous bacterial peptide from Spiroplasma citri induced a Th0-type response. Interestingly, the spleen cell response to the bacterial peptide and p127-142 was cross-reactive, that is, able to induce reciprocally the proliferation and cytokine production of primed spleen cells in vitro. More importantly, the peptides were able to skew the phenotype of T cells primed with the other peptide. Our results suggest that modified peptides can be useful in allergen immunotherapy.


Subject(s)
Allergens/immunology , Immunodominant Epitopes/immunology , Animals , Antigens, Bacterial/immunology , Antigens, Plant , Cell Proliferation , Cells, Cultured , Cross Reactions , Cytokines/biosynthesis , Dose-Response Relationship, Immunologic , Female , Immunization/methods , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , Mice , Mice, Inbred Strains , Peptide Fragments/immunology , Spiroplasma citri/immunology , Spleen/immunology , Th2 Cells/immunology
6.
J Allergy Clin Immunol ; 119(4): 965-72, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17335888

ABSTRACT

BACKGROUND: Peptide immunotherapy is a promising alternative for treating allergic diseases. One way to enhance the efficacy of peptide immunotherapy is to use altered peptide ligands (APLs) that contain amino acid substitutions compared with the natural peptide. OBJECTIVE: To evaluate the potential of an APL of the immunodominant epitope of lipocalin allergen Bos d 2 for peptide immunotherapy. METHODS: Peripheral blood CD4(+) T-cell responses of 8 HLA-DR4-positive subjects to the natural ligand of Bos d 2 (p127-142) or to an APL (pN135D) were analyzed by MHC class II tetramer staining after in vitro expansion with the peptides. Long-term T-cell lines (TCLs) were induced with the peptides, and the cytokine production, cross-reactivity, and T-cell receptor Vbeta subtype expression of the TCLs were analyzed. RESULTS: CD4(+) T cells specific for both p127-142 and pN135D were readily detected in peripheral blood after a single in vitro stimulation. Whereas the TCLs induced with p127-142 were T(H)2/T(H)0-deviated, those induced with pN135D were T(H)1/T(H)0-deviated and highly cross-reactive with p127-142. Moreover, the pN135D-induced TCLs appeared to use a broader repertoire of T-cell receptor Vbeta subtypes than those induced with p127-142. CONCLUSION: An APL of an immunodominant allergen epitope was able to induce a novel T(H)1-deviated T-cell population cross-reactive with the natural epitope in vitro. This cell population could have a therapeutic immunomodulatory function in vivo through bystander suppression. CLINICAL IMPLICATIONS: These results support the idea that altered peptide ligands may be used to enhance the efficacy of peptide immunotherapy.


Subject(s)
Allergens/metabolism , Allergens/therapeutic use , Desensitization, Immunologic , Peptide Fragments/immunology , Peptide Fragments/therapeutic use , Allergens/immunology , Amino Acid Substitution/genetics , Animals , Antigens, Plant , Asthma/immunology , Asthma/metabolism , Asthma/therapy , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Cattle , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Line , Desensitization, Immunologic/methods , Humans , Ligands , Multigene Family/immunology , Peptide Fragments/metabolism , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/genetics
7.
Immunology ; 120(1): 38-46, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17233739

ABSTRACT

We have previously shown that the major dog allergen Can f 1 contains seven T cell epitope regions, none of which was preferentially recognized. To identify the immune characteristics of Can f 1 epitopes and to verify their suitability for peptide-based allergen immunotherapy, short-term T cell lines were generated with epitope-containing peptides from peripheral blood mononuclear cells of Can f 1 skinprick test-positive allergic and healthy control subjects. The lines were examined for their proliferative capacity and cytokine production upon stimulation with the allergen peptide, a homologous peptide from human tear lipocalin (TL) and Can f 1 and TL proteins. Can f 1 peptides induced proliferation of T cells and gave rise to T cell lines with comparable efficiencies. In particular, the T cell lines of allergic subjects induced with p33-48 and p107-122 favoured the production of interferon-gamma and interleukin-10, respectively. A greater number of Can f 1-specific T cell lines were generated from allergic than from healthy individuals. Two p107-122-induced Can f 1-specific T cell lines also reacted to a homologous peptide of human TL. Our results suggest that several T cell epitope-containing peptides should be used in combination for specific immunotherapy in Can f 1 allergy.


Subject(s)
Allergens/immunology , Epitopes, T-Lymphocyte/immunology , Hypersensitivity/immunology , Animals , Antigens, Plant , Cell Line , Cell Proliferation , Cells, Cultured , Cytokines/biosynthesis , Dogs , Dose-Response Relationship, Immunologic , Feasibility Studies , Humans , Hypersensitivity/therapy , Immunophenotyping , Immunotherapy/methods , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Lymphocyte Activation/immunology , Peptide Fragments/immunology , Peptide Fragments/therapeutic use , T-Lymphocytes/immunology
8.
Int Immunol ; 17(12): 1573-81, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16221722

ABSTRACT

Peptide-based allergen immunotherapy is a novel alternative for conventional allergen immunotherapy. Here, we have characterized the immunomodulatory potential of heteroclitic peptide analogs of the immunodominant epitope of lipocalin allergen Bos d 2 on specific human T-cell clones. The TCR affinity of Bos d 2-specific T-cell clones for the natural peptide ligand and its heteroclitic analogs was assessed with fluorescent-labeled MHC class II tetramers. The activation and cytokine production of the clones were analyzed upon stimulation with the different ligands. Moreover, the capacity of the heteroclitic analogs to induce hyporesponsiveness and cell death was examined. The T-cell clones F1-9 and K3-2 bound MHC class II tetramers loaded with the heteroclitic peptide analogs of the immunodominant epitope of Bos d 2 with increased affinity. At similar peptide concentrations, stimulation of the clones with the heteroclitic analogs favored increased IFN-gamma/IL-4 and IFN-gamma/IL-5 ratios in comparison with stimulation with the natural peptide ligand. Moreover, the T-cell clones stimulated with the heteroclitic analogs exhibited an increased susceptibility to cell death or hyporesponsiveness upon re-stimulation. Our results suggest that heteroclitic analogs of a T-cell epitope of an allergen may enhance the efficacy of peptide-based allergen immunotherapy.


Subject(s)
Allergens/immunology , Epitopes, T-Lymphocyte/immunology , Heterocyclic Compounds/immunology , Immunodominant Epitopes/immunology , T-Lymphocytes/immunology , Allergens/therapeutic use , Antigens, Plant , Cytokines/immunology , Epitopes, T-Lymphocyte/therapeutic use , Heterocyclic Compounds/therapeutic use , Histocompatibility Antigens Class II/immunology , Humans , Hypersensitivity/immunology , Hypersensitivity/therapy , Immunotherapy/methods , T-Lymphocytes/cytology
9.
J Immunol ; 175(6): 3614-20, 2005 Sep 15.
Article in English | MEDLINE | ID: mdl-16148105

ABSTRACT

One prerequisite for developing peptide-based allergen immunotherapy is knowing the T cell epitopes of an allergen. In this study, human T cell reactivity against the major dog allergen Can f 1 was investigated to determine peptides suitable for immunotherapy. Seven T cell epitope regions (A-G) were found in Can f 1 with specific T cell lines and clones. The localization of the epitope regions shows similarities with those of the epitopes found in Bos d 2 and Rat n 1. On average, individuals recognized three epitopes in Can f 1. Our results suggest that seven 16-mer peptides (p15-30, p33-48, p49-64, p73-88, p107-122, p123-138, and p141-156), each from one of the epitope regions, show widespread T cell reactivity in the population studied, and they bind efficiently to seven HLA-DRB1 molecules (DRB1*0101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1101, DRB1*1301, and DRB1*1501) predominant in Caucasian populations. Therefore, these peptides are potential candidates for immunotherapy of dog allergy.


Subject(s)
Allergens/immunology , Epitopes, T-Lymphocyte/immunology , Immunotherapy/methods , Peptide Fragments/immunology , T-Lymphocytes/immunology , Allergens/therapeutic use , Animals , Antigens, Plant , Cells, Cultured , Dogs , Epitope Mapping , HLA-DR Antigens/immunology , HLA-DRB1 Chains , Humans , Hypersensitivity/therapy , Peptide Fragments/therapeutic use , T-Lymphocytes/cytology
10.
Eur J Immunol ; 33(6): 1717-26, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12778490

ABSTRACT

We have proposed earlier that the poor capacity of the lipocalin allergen Bos d 2 to stimulate highly allergic subjects' peripheral blood mononuclear cells could be ascribed to endogenous lipocalins and could be related to the allergenic potential of the molecule. Here, we have characterized the proliferative and cytokine responses of human T cell clones against the immunodominant epitope of Bos d 2. We observed, for clone F1-9, that a substitution of aspartic acid for asparagine in the core region of the epitope increased the stimulatory capacity of the peptide about 100-fold in comparison with the natural peptide. For clone K3-2, from a different patient, the substitution of lysine for glutamine or isoleucine for leucine in the core region resulted in about 30-fold and 10-fold increases in the stimulatory capacity of the peptides, respectively. The clones also recognized self-protein-derived peptides but not the peptides derived from other lipocalins. We suggest that the poor recognition of the immunodominant epitope of Bos d 2 can be a factor accounting for Bos d 2-allergic subjects' weak cellular responses. Suboptimal recognition of self and allergen epitopes by T cells may be of significance for the allergenicity of proteins.


Subject(s)
Allergens/immunology , Carrier Proteins/immunology , Cattle/immunology , Epitopes, T-Lymphocyte/immunology , Immunodominant Epitopes/immunology , T-Lymphocyte Subsets/immunology , Amino Acid Sequence , Amino Acid Substitution , Animals , Antigens, Heterophile/immunology , Antigens, Plant , Asthma/etiology , Autoantigens/immunology , Clone Cells/immunology , Cross Reactions , Dust , HLA-DR Antigens/immunology , HLA-DR Antigens/metabolism , HLA-DRB1 Chains , HLA-DRB4 Chains , Humans , Lymphocyte Activation , Molecular Sequence Data , Peptide Fragments/chemical synthesis , Peptide Fragments/immunology , Protein Binding , Sequence Alignment , Structure-Activity Relationship
11.
Int Immunol ; 14(4): 401-9, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11934876

ABSTRACT

The immunological characteristics of an important group of animal-derived allergens, lipocalins, are poorly known. To explore the immunology of the lipocalin allergen Bos d 2, several mouse strains with different H-2 haplotypes were immunized with the allergen. Only the BALB/c mouse mounted a distinct humoral response against Bos d 2. The proliferative spleen cell responses of all mouse strains remained very weak. Further experiments with BALB/c mice confirmed that Bos d 2 is a weak inducer of both humoral and cellular responses, and that the responses were weaker than with the control antigens hen egg lysozyme (HEL) and tetanus toxoid. IgG subclass analyses showed that Bos d 2 was prone to favor the T(h)2 response. Although s.c. immunization using complete Freund's adjuvant favored the T(h)1-deviated immune response by lymph node cells, Bos d 2 was able to induce the production of IL-4 while the control antigen HEL did not. Epitope mapping revealed that BALB/c mice recognized one immunodominant epitope in Bos d 2, almost identical to that recognized by humans. The epitope was shown to be immunogenic in subsequent experiments. However, further studies are needed to clarify the significance of priming and stimulation doses of the immunodominant and other epitopes in Bos d 2 for the outcome of immune response against the allergen. The murine immune response against Bos d 2 closely resembled that observed in humans. The weak immunogenicity of Bos d 2 may be associated with its allergenicity.


Subject(s)
Allergens/immunology , Carrier Proteins/immunology , Cytokines/biosynthesis , Animals , Antigens, Plant , Carrier Proteins/metabolism , Chickens/anatomy & histology , Chickens/immunology , Egg Proteins/immunology , Epitopes , Female , Immunity, Cellular , Immunoglobulin G/classification , Immunoglobulin G/immunology , Lymph Nodes/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Inbred Strains , Muramidase/immunology , Spleen/immunology , T-Lymphocytes/immunology , Tetanus Toxoid/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...